The fight for dominance between Regeneron and Bayer’s big blockbuster eye drug Eylea and Roche’s rival Vabysmo is playing out ...
The ACA marketplace at HealthCare.gov is a great way to find health insurance if you can’t get coverage through work. Our ratings take into account a product's cost, features, ease of use ...
Bayer Thai Co., Ltd., has been honored with the prestigious 2025 Thailand Best Employer Brand Award, presented by the World ...
Berenberg Bank analyst Sebastian Bray maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €22.00. The ...
The "Enterprise Tech Ecosystem Series: Bayer AG 2024" report has been added to ResearchAndMarkets.com's offering. The report provides insights into Bayer AG's tech activities, including its digital ...
Female entrepreneurs in the fields of health and food security have the chance to receive significant support through the Bayer Foundation Women Entrepreneurs Award (WEA) 2025, including a cash prize ...
The "Soft Tissue Sarcoma Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering. The global market for Soft ...
Dr. Jeff Wessler (MD MPhil FACC) is a virtual cardiologist, the Founder of Heartbeat Health, and on clinical faculty at Northwell Health. The year 2025 looms large for healthcare—a field ...
Copyright 2025 The Associated Press. All Rights Reserved. Leverkusen’s head coach Xabi Alonso looks on ahead of the German Bundesliga soccer match between Borussia ...
The optimism is rooted in new launches, Stefan Oelrich, head of Bayer’s pharma division, said Tuesday at the J.P. Morgan Healthcare Conference. Besides label expansions for in-market products ...
Bayer AG’s Monsanto unit stopped making toxic PCBs a half century ago, but the legal fallout lingers even as many of the building materials made with the chemicals are no longer used in US homes ...
Trial was the latest over harm tied to school outside Seattle Company vows appeal of verdict and ‘excessive’ damages awarded Bayer AG was told by a jury to pay $100 million to four people at a Seattle ...